does glp 1 affect kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity GLP-1 drugs are changing more

From payer friction to behavioral drop-off, GLP-1s are challenging pharma to rethink how success is measured in the obesity and diabetes markets

Functional trainers are also joint-friendly by design

Choosing the right injection site for GLP-1 medications involves understanding anatomy, absorption patterns, and individual tolerance

Implications for Small Pharmacies and the Medical Device Sector Contrary to expectations, the popularity of GLP-1 drugs poses economic challenges for small pharmacies, with many reporting losses due to the disparity between acquisition costs and reimbursement rates

3 : Use EHR and claims data to identify overdose survivors and measure long-term outcomes across different treatment approaches

But to understand why they work, you need to know what theyre actually doing inside your body